Elevation Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.38K Buy
545
+468
+608% +$5.6K ﹤0.01% 914
2026
Q1
$461 Sell
77
-1,118
-94% -$8.41K ﹤0.01% 1047
2025
Q4
$8.57K Buy
1,195
+1,118
+1,452% +$8.83K ﹤0.01% 512
2025
Q3
$818 Buy
77
+1
+1% +$10 ﹤0.01% 759
2025
Q2
$740 Hold
76
﹤0.01% 445
2025
Q1
$1.14K Buy
76
+1
+1% +$15 ﹤0.01% 441
2024
Q4
$1.12K Buy
75
+1
+1% +$16 ﹤0.01% 448
2024
Q3
$1.42K Hold
74
﹤0.01% 428
2024
Q2
$1.52K Buy
74
+1
+1% +$20 ﹤0.01% 458
2024
Q1
$1.37K Sell
73
-11
-13% -$189 ﹤0.01% 427
2023
Q4
$1.46K Hold
84
﹤0.01% 401
2023
Q3
$1.46K Buy
84
+1
+1% +$21 ﹤0.01% 300
2023
Q2
$1.73K Hold
83
﹤0.01% 309
2023
Q1
$1.94K Buy
+83
New +$2.23K ﹤0.01% 307

Other funds holding OGN

Elevation Wealth Partners's OGN Position: Q2 2026 in Review

Elevation Wealth Partners increased its Organon & Co (OGN) stake by 608% in Q2 2026, buying an estimated $5.6K and bringing the position to 545 shares worth $7.38K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Elevation Wealth Partners first reported a position in OGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.57K in Q4 2025. 196 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Elevation Wealth Partners held 545 shares of Organon & Co worth $7.38K as of Q2 2026.
  • Elevation Wealth Partners bought 468 Organon & Co shares in Q2 2026, an estimated $5.6K.
  • Organon & Co made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #914 holding.
  • Elevation Wealth Partners first reported a position in Organon & Co in Q1 2023 and has held it in 14 quarters since.
  • Elevation Wealth Partners's Organon & Co position peaked at $8.57K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.